Market Overview

Genetics Technologies Executes Deal with InterWest Health of Missoula, Montana

Share:
Related GENE
Genetic Technologies Announces Settlement and Release Agreement With Hendrix Genetics
Genetic Technologies Announces Publication of Key Scientific Validation Results in Support of BREVAGenplus

Genetic Technologies Limited (NASDAQ: GENE) is pleased to announce that, through its wholly-owned subsidiary Phenogen Sciences Inc., it has executed an agreement with InterWest Health of Missoula, Montana, USA, to use the InterWest provider network. InterWest Health is a regional provider network servicing seven north-western US states, including Montana, Idaho and Washington, that includes more than 15,000 health care providers. The agreement with InterWest Health is the eighth such credentialing agreement executed between the Company and similar US Preferred Provider Organisations (“PPOs”). The cumulative total number of covered lives for which its BREVAGen™ risk assessment test could be adjudicated as “in-network” now exceeds 102 million.

Posted-In: News Contracts

 

Related Articles (GENE)

View Comments and Join the Discussion!

Get Benzinga's Newsletters